BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Biodel Inc. Diabetes Phase 3 Study Disappoints

  September 8, 2008

   · 

  11 min read
• Progen Pharmaceuticals Limited Receives NASDAQ Deficiency Notice

  September 8, 2008

   · 

  1 min read
• Drug Development

  XOMA (US) LLC 052 Clinical Results Support New Type 2 Diabetes Therapeutic Approach of Targeting Inflammatory Damage to Insulin-Producing Cells

  September 8, 2008

   · 

  1 min read
• BioForest

  CombiMatrix Corporation to Hold Conference Call to Discuss Recent Findings Utilizing Its HemeScan Test for Chronic Lymphocytic Leukemia Patients

  September 8, 2008

   · 

  1 min read
• Business

  Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration

  September 8, 2008

   · 

  4 min read
• Smith & Nephew Inc. - Transaction in Own Shares

  September 8, 2008

   · 

  1 min read
• Business

  Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research

  September 8, 2008

   · 

  2 min read
• Deals

  Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab

  September 8, 2008

   · 

  2 min read
• FDA

  Janssen-Cilag International NV, Ortho Biotech Products, L.P. VELCADE(R) Approved For Previously Untreated Multiple Myeloma

  September 8, 2008

   · 

  2 min read
• Policy

  Ortho Biotech Products, L.P. Files sNDA for DOXIL(R) for the Treatment of Advanced Breast Cancer

  September 8, 2008

   · 

  8 min read